4 One study showed these tend to be mild to moderate, occurring primarily when increasing dosage levels
Kirby, M.D., Ph.D., associate professor in the Division of Endocrinology and Metabolism at the University of Virginia Health System
As butyrate-producing bacteria are known to improve intestinal barrier function, decreased amount of these bacteria in IBS-D and IBS-M patients could have led to impairment in intestinal permeability and activate the nociceptive sensory pathways, which manifest in the symptoms observed
however, some viruses readily replicate despite ROS induction, suggesting that ROS can exert bidirectional effects on viral replication 59
Thats different from FDA-approved and over-the-counter medications
As GLP-1 utilization expanded, new patient volume for hypertension and high cholesterol therapies declined, with 2024 marking the steepest drop, 3% for hypertension and 4% for high cholesterol